These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27194713)

  • 1. Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury.
    Skrypnyk NI; Voziyan P; Yang H; de Caestecker CR; Theberge MC; Drouin M; Hudson B; Harris RC; de Caestecker MP
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F268-77. PubMed ID: 27194713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with PTBA analogs reduces postinjury renal fibrosis after kidney injury.
    Skrypnyk NI; Sanker S; Skvarca LB; Novitskaya T; Woods C; Chiba T; Patel K; Goldberg ND; McDermott L; Vinson PN; Calcutt MW; Huryn DM; Vernetti LA; Vogt A; Hukriede NA; de Caestecker MP
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F705-F716. PubMed ID: 26661656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
    Li Q; Chen C; Chen X; Han M; Li J
    Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation.
    Nishida K; Watanabe H; Murata R; Tokumaru K; Fujimura R; Oshiro S; Nagasaki T; Miyahisa M; Hiramoto Y; Nosaki H; Imafuku T; Maeda H; Fukagawa M; Maruyama T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains.
    Tewes S; Gueler F; Chen R; Gutberlet M; Jang MS; Meier M; Mengel M; Hartung D; Wacker F; Rong S; Hueper K
    PLoS One; 2017; 12(3):e0173248. PubMed ID: 28319118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.
    Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis.
    Yu H; Lin T; Chen W; Cao W; Zhang C; Wang T; Ding M; Zhao S; Wei H; Guo H; Zhao X
    Biomaterials; 2019 Oct; 219():119368. PubMed ID: 31349200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
    Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol attenuates rhabdomyolysis-associated acute kidney injury: Renal and muscular protection.
    Gois PHF; Canale D; Volpini RA; Ferreira D; Veras MM; Andrade-Oliveira V; Câmara NOS; Shimizu MHM; Seguro AC
    Free Radic Biol Med; 2016 Dec; 101():176-189. PubMed ID: 27769920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
    Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
    Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
    Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice.
    Soranno DE; Rodell CB; Altmann C; Duplantis J; Andres-Hernando A; Burdick JA; Faubel S
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F362-72. PubMed ID: 26962109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy.
    Shi M; Flores B; Gillings N; Bian A; Cho HJ; Yan S; Liu Y; Levine B; Moe OW; Hu MC
    J Am Soc Nephrol; 2016 Aug; 27(8):2331-45. PubMed ID: 26701976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
    Li C; Xie N; Li Y; Liu C; Hou FF; Wang J
    Free Radic Biol Med; 2019 Jan; 130():512-527. PubMed ID: 30447351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis.
    Johnson FL; Patel NSA; Purvis GSD; Chiazza F; Chen J; Sordi R; Hache G; Merezhko VV; Collino M; Yaqoob MM; Thiemermann C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.
    Guo J; Guan Q; Liu X; Wang H; Gleave ME; Nguan CY; Du C
    BMC Nephrol; 2016 Sep; 17(1):133. PubMed ID: 27649757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preischemic Administration of Nonexpanded Adipose Stromal Vascular Fraction Attenuates Acute Renal Ischemia/Reperfusion Injury and Fibrosis.
    Zhou L; Xu L; Shen J; Song Q; Wu R; Ge Y; Xin H; Zhu J; Wu J; Jia R
    Stem Cells Transl Med; 2016 Sep; 5(9):1277-88. PubMed ID: 27365485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.
    Le Clef N; Verhulst A; D'Haese PC; Vervaet BA
    PLoS One; 2016; 11(3):e0152153. PubMed ID: 27007127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.